OCEAN BIOMEDICAL, INC. Business Combination, Acquisition Related Costs
OCEAN BIOMEDICAL, INC. (OCEA) reported Business Combination, Acquisition Related Costs of $7.58 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2025-04-08
- OCEAN BIOMEDICAL, INC. business combination, acquisition related costs for the quarter ending 2023-12-31 was $0.00.
- OCEAN BIOMEDICAL, INC. business combination, acquisition related costs for the quarter ending 2023-09-30 was $0.00.
- OCEAN BIOMEDICAL, INC. business combination, acquisition related costs for the quarter ending 2023-06-30 was $0.00.
- OCEAN BIOMEDICAL, INC. business combination, acquisition related costs for the quarter ending 2023-03-31 was $7.58M.
- OCEAN BIOMEDICAL, INC. business combination, acquisition related costs for fiscal 2023 was $7.58M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 3 month as first filed | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 6 month as first filed | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $0.00 derived: sum of 2 quarters · filed 2025-04-08 | $0.00 derived: sum of 3 quarters · filed 2025-04-08 | $7.58M 10-K · filed 2025-04-08 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-13 | $0.00 derived: sum of 2 quarters · filed 2025-01-13 | $7.58M 10-Q · filed 2025-01-13 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-23 | $7.58M 10-Q · filed 2024-12-23 | $7.43M 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $7.58M 10-Q · filed 2024-12-23 | $7.43M 10-Q · filed 2023-05-24 |